Tag: LILRB4

Tag Visualization: Top 50 related tags by occurrence

Clinical medicine: 1 articleClinical medici...Cell biology: 1 articleCell biologyOncology: 2 articlesOncologyImmunology: 2 articlesImmunologyImmune system: 1 articleImmune systemVISTA: 1 articleVISTAPALO ALTO: 1 articlePALO ALTOTumor microenvironment: 2 articlesTumor microenvironmentCancer immunotherapy: 1 articleCancer immunoth...Branches of biology: 1 articleBranches of bio...Adoptive cell transfer: 1 articleAdoptive cell t...Cancer immunology: 1 articleCancer immunolo...Medical specialties: 2 articlesMedical specialtiesOrgan systems: 1 articleOrgan systemsAcute myeloid leukemia: 2 articlesAcute myeloid leukemiaClusters of differentiation: 1 articleClusters of dif...Myeloid-derived suppressor cell: 1 articleMyeloid-derived...NGM Biopharmaceuticals Inc.: 1 articleNGM Biopharmace...Leukemia & Lymphoma Society: 1 articleLeukemia & Lymp...Fibronectin: 1 articleFibronectinImmunoglobulin superfamily: 2 articlesImmunoglobulin superfa...Chronic myelomonocytic leukemia: 2 articlesChronic myelomonocytic...LILRB4: 3 articlesLILRB4Immune-Onc Therapeutics Inc.: 1 articleImmune-Onc Ther...Stuart Lutzker: 1 articleStuart LutzkerOnc Therapeutics, Inc.: 1 articleOnc Therapeutic...Leukocyte immunoglobulin-like receptors: 1 articleLeukocyte immun...

Recent Related Articles to LILRB4

Immune-Onc Therapeutics Appoints Stuart Lutzker, MD, Ph.D. to Scientific Advisory Board

Added to Collection on: 2021-05-04 15:00:00

Tags for this article:

Click the tags to see associated articles and topics

View Article Details
NGM Bio Discloses Fourth Oncology Development Candidate, NGM831, an ILT3 Antagonist ...

Added to Collection on: 2021-08-23 12:00:00

Tags for this article:

Click the tags to see associated articles and topics

View Article Details
Immune-Onc Therapeutics Doses First Patient in Phase 1 Clinical Trial of IO-202, a First ... - WVNews

Added to Collection on: 2022-04-12 20:43:17

Tags for this article:

Click the tags to see associated articles and topics

View Article Details